Dr. Gary C. Bellman, MD

Dr. Bellman practices at Dignity Health - Northridge Hospital Medical Center in Northridge, California, part of CommonSpirit Health.

Dr. Bellman's NPI, 1588735468, was assigned on November 13, 2006. Dr. Bellman graduated from McGill University Faculty of Medicine in 1987. Dr. Bellman holds California license A51907.

Dr. Bellman's primary practice is Dignity Health - Northridge Hospital Medical Center, at 18300 Roscoe Blvd, Northridge, CA 91325 in Los Angeles County. The practice phone is (818) 885-8500.

Dr. Bellman's primary practice is Dignity Health - Northridge Hospital Medical Center in Northridge, California, part of CommonSpirit Health. Dr. Bellman is also affiliated with UCLA West Valley Medical Center. Dmand AI also links Dr. Bellman to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bellman practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Bellman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Bellman is board certified in urology by the American Board of Urology. Dmand AI has Dr. Bellman's licenses on file in 2 states: California and New York.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, testicular dysfunction, transurethral procedures and urinary endoscopy among the conditions Dr. Bellman treats.

CMS data shows 1,313 Medicare services from Dr. Bellman across 14 procedure codes in 2024, for 393 Medicare patients. Medicare paid $333,704 for them.

CMS counts 393 Medicare patients who saw Dr. Bellman in 2024. The largest group is 65 to 74, with 186 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bellman's median patient age at 66, with 10% women.

In 2024, Dr. Bellman wrote 762 Medicare Part D claims for 235 patients. 92% of them were for generic drugs. CMS names the drug for 665 of them, across 15 drugs with 11 or more claims each, at $59,794 in total drug cost. In 2023, CMS named 855 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Bellman for performance year 2024, reported individually. Dr. Bellman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 31 papers to Dr. Bellman. The most frequent topics are Nephrostomy, Percutaneous, Kidney Calculi and Kidney Diseases. Dr. Bellman has published most often in J Endourol. Dr. Bellman's most frequent co-authors are Hetal S. Patel, MD, Ronald Ming Yang, MD and Marshall L. Stoller, MD.

CMS Open Payments shows 40 general payments to Dr. Bellman from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 79% of the total. NxThera, Inc. paid the most, $543.

Dmand AI lists 1 award for Dr. Bellman, most recently CMS Stage 1 2012 in 2011.

Dr. Bellman graduated from McGill University Faculty of Medicine in 1987.

Dr. Bellman is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.